Latest News

Investors are searching for clarity, and they could get a lot of answers soon.

The companies are going head to head in kidney disease. Here's why Novartis could have a slight advantage.

Turkey's March data shows a better-than-expected turnout, but recent currency weakness could result in upward pressure on April inflation.

EXELIXIS INC is a hidden gem, featuring undervaluation and robust fundamentals. NASDAQ:EXEL showcases decent financial health and profitability, coupled with an attractive price.

Silver remains in an uptrend with buyers eyeing pullbacks as entry points, especially near $33.33, while a breakout above $35 could signal a major move higher.

Known for his philosophy of investing in what you know, Peter Lynch looked for companies with consistent earnings growth, low debt, and a competitive edge. Does IBEX LTD (NASDAQ:IBEX) meet these key criteria? Let’s find out.

The holds are temporary while the teenager's death is under investigation.

Trump tariffs hit the stock market Thursday.

The brokerage warned that semiconductor stocks could see at least a 20% additional downside if the tariffs trigger a recession.

Acuity Brands reported Q2 2025 sales growth of 11.1%, missing analyst estimates. Adjusted EPS beat estimates. ABL revenue decreased while AIS revenue increased.

Little would one know from looking at the US economic outperformance and the record-high household net worth, but the US President said that global trade has “looted, pillaged, raped, and plundered” the US economy.

EVERGY INC (NASDAQ:EVRG) has a good technical rating of 10 out of 10 and could possibly break out.

XRP (CRYPTO: XRP) is down 13% in a week but retail demand surging and active addresses hitting new highs may signal a reversal in the medium term.